Target intelligence / Profile preview

Endothelial heparan sulfate proteoglycans (Endothelial HSPGs)

Target
Endothelial HSPGs
Molecular classification
Receptor, Other
01

Overview

Endothelial heparan sulfate proteoglycans (HSPGs) are highly glycosylated proteins located on the luminal surface of vascular endothelial cells and within the basement membrane, serving as a major structural and functional component of the endothelial glycocalyx. They consist of a core protein (such as syndecans or glypicans) covalently linked to negatively charged heparan sulfate glycosaminoglycan chains. Endothelial HSPGs play critical roles in maintaining vascular homeostasis by regulating vascular permeability, microcirculatory tone, leukocyte adhesion, and coagulation. They also act as mechanosensors of fluid shear stress and serve as co-receptors or reservoirs for various growth factors, chemokines, and cytokines (such as FGF, VEGF, and IL-8). In pathological states like sepsis, inflammation, and cancer, endothelial HSPGs are shed from the cell surface through the action of sheddases and heparanase, leading to glycocalyx degradation, vascular leakage, and thrombosis. Therapeutic strategies targeting endothelial HSPGs include heparan sulfate mimetics, heparanase inhibitors, and low-molecular-weight heparins, which aim to preserve glycocalyx integrity, competitively block pathological ligand binding, or neutralize circulating inflammatory mediators.

Other names
Endothelial cell surface heparan sulfate proteoglycansVascular endothelial heparan sulfate proteoglycansEndothelial glycocalyx heparan sulfate proteoglycansEndothelial HSPGs
02

Mechanism of action

Competitive inhibition of ligand binding to heparan sulfate chains, stabilization of endothelial glycocalyx, inhibition of heparanase-mediated degradation, or neutralization of circulating histones and inflammatory mediators.

03

Biological functions

Signal transductionCell adhesionImmune responseOther
04

Disease associations

Cardiovascular diseaseInflammationInfectionCancerOther
05

Safety considerations

Bleeding riskThrombocytopeniaImpaired wound healingOff-target anticoagulant effectsHypersensitivity reactions
06

Interacting drugs

8 more in the full profile.

07

Biomarkers

Soluble Syndecan-1Circulating Heparan SulfateHeparanase activityAngiopoietin-2

Beyond the preview

Go deeper on Endothelial heparan sulfate proteoglycans (Endothelial HSPGs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endothelial heparan sulfate proteoglycans (Endothelial HSPGs).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call